Lodderomyces elongisporus endocarditis in an intravenous drug user: a new entity in fungal endocarditis.
Lodderomyces elongisporus has been recently identified in the literature as an infrequent human bloodstream isolate, commonly mistaken for a non-albicans Candida. A case of Lodderomyces endocarditis in an intravenous drug user is described. To our knowledge, this report highlights the first documented case of Lodderomyces as a cause of endocarditis and summarizes the susceptibility patterns in the reported literature. All isolates reported so far have fluconazole MICs of ≤0.25 µg ml(-1).
Infectious Diseases Unit, The Royal Brisbane and Women's Hospital, Butterfield Street, Herston, Queensland, Australia.
K L
KL
Daveson
Infectious Diseases Unit, The Royal Brisbane and Women's Hospital, Butterfield Street, Herston, Queensland, Australia.
M L
ML
Woods
D000328:Adult; D000935:Antifungal Agents / Q000494:pharmacology; D001393:Azoles / Q000494:pharmacology; D004696:Endocarditis / Q000382:microbiology*; D006801:Humans; D008297:Male; D009181:Mycoses / Q000382:microbiology*; D004718:Saccharomycetales / Q000145:classification* / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification*; D015819:Substance Abuse, Intravenous / Q000150:complications*
D000935:Antifungal Agents; D001393:Azoles